Triclocarbon Category I Antibacterial Efficacy Supported By Bayer Studies
This article was originally published in The Rose Sheet
Executive Summary
Triclocarbon in concentrations up to 1.5% should be included as a Category I active ingredient in the healthcare antiseptic tentative final monograph, Bayer says in a 1Dec. 28 citizen petition to FDA
You may also be interested in...
Triclosan Antiseptic Category I Status Requested By CIBA
FDA should consider new safety data supporting Category I (safe and effective) status for triclosan in the OTC Tentative Final Monograph for Health Care Antiseptic Drug Products, CIBA Specialty Chemicals and an alliance of six triclosan manufacturers/ marketers state in a Sept. 13 citizen petition.
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands
Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle